Aristotle University Of Thessaloniki (AUTH)
Φαρμακοχημική αξιοποίηση της ενονικής ομάδας: σχεδιασμός, σύνθεση, βιολογική μελέτη και υπολογισμός φυσικοχημικών χαρακτηριστικών
Abstract
dc:descriptionEpidemiological and experimental studies have already established the functional relationship between Alzheimer disease, oxidative stress and inflammation.The reason that creates AD and other dementias is not fully discovered nor the links among all those paths. Τhus, attempts have been made to clarify these relationships and to introduce new therapeutic agents. Scope of this thesis is the design and synthesis of new pleiotropic compounds using the enone moiety as a basic scaffold, which will have multiple biological activities. In the present study a series of compounds: 2-hydroxy(TL), 4-hydroxy(TA) and bis-chalcones(FWD), aurones(TAL), pyrazole(phh), pyrazoline(semi) and pyrimidine(gua,thio) enone derivatives was designed and synthesized using modified methods and methods derived from the literature. The synthesis was based on a Claisen-Schmidt condensation, etherification and cyclization. The structures of the synthesized compounds were confirmed by spectral and elemental analysis. Their lipophilicity is experimentally determined by reversed-phase thin-layer chromatography method. Physicochemical properties were theoretically calculated and their log BBB values were predicted.All compounds were tested as antioxidant agents in five different assays: i) for their ability to react with DPPH, ii) to scavenge the cationic radical ABTS (FWD3=99%), iii) to inhibit lipid peroxidation (FWD3=100%) (FWD3=82%) induced by AAPH, iv) to inhibit lipid peroxidation of liposomes, and v) to intereact with luminole. Compounds were evaluated in vitro for their ability to inhibit soybean lipoxygenase (FWD15 IC50=50μΜ, FWD3 IC50=56μΜ, FWD4 IC50=55μΜ). The most promising derivatives were tested against h-15-Lox (TL4 IC50=9,5μΜ). Compounds were also evaluated for their ability to inhibit AChE, to interact with GSH and to inhibit β-amyloid accumulation. The compounds were studied in vitro for their cytotoxitity and toxicity against mosquito larvae. Some of the derivatives were tested in vivo as possible anti-inflammatory agents in the carragenin protocol. However, the results were low. The most potent compound FWD3 was tested in vivo in several behavioral tests (Von Frey and Hot plate). The results are discussed in terms of structural and physicochemical characteristics of the compounds. Moreover, the pharmacokinetic profile and mode of metabolism of these compounds was investigated using computational methods. The pharmacokinetic findings seem quite interesting anduseful to the design and optimization of the pharmacokinetic profile of new derivatives. As the most probable sites of metabolism for the enzymes CYP1A1 and CYP1A2 are the hydrogens of the –CH2CH2CH2O– linkage, it seems possible that the ethers of the double chalcones act as active metabolites. Compounds FWD2 and FWD3 were found to be the most potent LOX and AChE inhibitors among the tested derivatives with a significant anti-lipid peroxidation profile. The α, β -unsaturated ketone moiety is considered the key pharmacophore feature. The presence of a double enone group supports better biological results, whereas the rest structural element seems to quantitatively offer to the activity. The results suggested FWD2 and FWD3 as new pleiotropic agents against AD. The presence of the enone moiety double/simple and /or of the conjugated double bond supports the biological results. The findings verify our design and principal hypothesis.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2016
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Liargkova, Thaleia
- Λιαργκόβα, Θάλεια
Subjects
dc:subject × 24- Ενόνες
- Χαλκόνες
- Αουρόνες
- Πλειοτροπικά μόρια
- Αντι-Αλτσχάιμερ θεραπεία
- Αντιφλεγμονώδη
- Αντιοξειδωτικά
- Αναστολείς ακετυλοχολινεστεράσης
- Αναστολείς λιποξυγονάσης
- Αμυλοειδείς πλάκες
- Enones
- Chalcones
- Aurones
- Pleiotropic agents
- Anti-Alzheimer therapy
- Anti-inflammatories
- Antioxidants
- Acety-cholinesterase inhibitors
- Lipoxygenase inhibitors
- Amyloids plaques
- Ιατρική και Επιστήμες Υγείας
- Επιστήμες Υγείας
- Medical and Health Sciences
- Health Sciences
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/39411